Literature DB >> 11508696

Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondria.

A P Rolo1, P J Oliveira, A J Moreno, C M Palmeira.   

Abstract

Several reports support the concept that bile acids may be cytotoxic during cholestatic disease process by causing mitochondrial dysfunction. Here we report additional data and findings aimed at a better understanding of the involvement of the permeability transition pore (PTP) opening in bile acids toxicity. The mitochondrial PTP is implicated as a mediator of cell injury and death in many situations. In the presence of calcium and phosphate, chenodeoxycholic acid (CDCA) induced a permeability transition in freshly isolated rat liver mitochondria, characterized by membrane depolarization, release of matrix calcium, and osmotic swelling. All these events were blocked by cyclosporine A (CyA) and the calcium uniporter inhibitor ruthenium red (RR). The results suggest that CDCA increases the sensitivity of isolated mitochondria in vitro to the calcium-dependent induction of the PTP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508696     DOI: 10.1023/a:1010438202519

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  6 in total

1.  Bile acids as constituents for dental composites: in vitro cytotoxicity of (meth)acrylate and other ester derivatives of bile acids.

Authors:  Marc A Gauthier; Pierre Simard; Zhao Zhang; X X Zhu
Journal:  J R Soc Interface       Date:  2007-12-22       Impact factor: 4.118

2.  Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.

Authors:  Tomomichi Iwaki; Kaoru Ishizaki; Shuji Kinoshita; Hideki Tanaka; Atsushi Fukunari; Makoto Tsurufuji; Teruaki Imada
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

3.  Mitochondrial disorders in NSAIDs-induced small bowel injury.

Authors:  Toshio Watanabe; Tetsuya Tanigawa; Yuji Nadatani; Koji Otani; Hirohisa Machida; Hirotoshi Okazaki; Hirokazu Yamagami; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Clin Biochem Nutr       Date:  2011-02-26       Impact factor: 3.114

4.  Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.

Authors:  Zizhen Gong; Jiefei Zhou; Shengnan Zhao; Chunyan Tian; Panliang Wang; Congfeng Xu; Yingwei Chen; Wei Cai; Jin Wu
Journal:  Oncotarget       Date:  2016-12-20

5.  Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.

Authors:  Paula Iruzubieta; Naroa Goikoetxea-Usandizaga; Lucía Barbier-Torres; Marina Serrano-Maciá; David Fernández-Ramos; Pablo Fernández-Tussy; Virginia Gutiérrez-de-Juan; Sofia Lachiondo-Ortega; Jorge Simon; Miren Bravo; Fernando Lopitz-Otsoa; Mercedes Robles; Carlos Ferre-Aracil; Marta Varela-Rey; Natalia Elguezabal; José Luis Calleja; Shelly C Lu; Malgorzata Milkiewicz; Piotr Milkiewicz; Juan Anguita; María J Monte; José J G Marin; Marcos López-Hoyos; Teresa C Delgado; Mercedes Rincón; Javier Crespo; María Luz Martínez-Chantar
Journal:  JHEP Rep       Date:  2021-03-18

Review 6.  Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review.

Authors:  Toshio Watanabe; Yasuhiro Fujiwara; Francis K L Chan
Journal:  J Gastroenterol       Date:  2019-12-21       Impact factor: 7.527

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.